Initial vaccination with an alphavirus replicon based vaccine followed by a booster has been shown to protect mice, and promising DNA vaccines based on RVFV genes fused with genes encoding molecular adjuvants have shown promise in mouse trials (16, 17 ).
It was the configuration used during in vivo mouse trials.
Comparing the immune responses in a mouse trial, mice which were vaccinated with Salmonella to express the HA protein inside cell (under the control of the starvation induced S. enterica sspA promoter) did not show robust T cell and humoral responses in comparison to mice vaccinated with HA protein expressed in yeast.
We did not observe galloping or bounding even at the highest speeds (cf. Bellardita and Kiehn, 2015), probably because the mice freely initiated trials in our experiments, rather than being placed in the corridor by the experimenter at the start of each trial.
Subjects were required to press the left or right button of a mouse in trials where they did or did not find the target respectively (two-alternative forced choice).
Although in vitro studies and trials in mouse models of MS seem to be very encouraging about the therapeutic potential of DNMT and histone deacetylase inhibitors, the contradictions mentioned should be taken into consideration [55].
48 Therapeutic antibodies targeting CD30 have been developed, and while demonstrating impressive preclinical activity in xenograft mouse models, early clinical trials in HL and ALCL have shown only modest efficacy.
Collectively, the data here reported lay the foundation for preclinical trials in mouse models of SBMA to test the therapeutic potential of Bicalutamide and trehalose in single or combined administration.
In our mice trial, the median TTP was 59 days for the alternated sequences of treatment, which represent a 64% increased compared with the mTTP of sunitinib.
However, failure to translate positive preclinical findings achieved in these mice into positive clinical trials in ALS patients has raised concerns about the relevance of SOD1 mouse models to ALS (as well as highlighted the need to carry out high-quality clinical trials) (Benatar, 2007; Scott et al., 2008).
